Asia-Pacific Injectable Anticoagulants Market Analysis 2012-2017 and Forecast 2018-2023

ReportPage
Report ID
29035
Published Date
25-Mar
No of Report Page
93
Report Category
Pharmaceuticals and Healthcare
Editor's Rating
US $6,600.00
US $6,600.00
US $3,300.00

  • Report Details

    Snapshot
    The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin?], enoxaparin [Lovenox?]) and factor Xa inhibitors (fondaparinux [Arixtra?]).In general, the injectable anticoagulants are Food and Drug Administration (FDA)-approved for prophylaxis and/or treatment of venous thromboembolism.
    The Asia-Pacific Injectable Anticoagulants market will reach x

    More...
  • Table Of Content

    Table of Content
    1 Industry Overview
    1.1 Injectable Anticoagulants Industry
    1.1.1 Overview
    1.1.2 Development of Injectable Anticoagulants
    1.2 Market Segment
    1.2.1 By Product Type
    1.2.2 By Application
    1.3 Asia-Pacific Overview
    2 Major Companies List
    2.1 Genentech (Roche) (Company Profile, Products & Services, Sales Data etc.)
    2.2 Sanofi (Company P

    More...
  • Inquiry Before Buying
    Inquiry Before Buying -
  • Request Sample
    Request For Sample